SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-134486
Filing Date
2021-11-04
Accepted
2021-11-04 17:05:28
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2131845-1_s3.htm S-3 411678
2 EXHIBIT 4.5 tm2131845d2_ex4-5.htm EX-4.5 355363
3 EXHIBIT 5.1 tm2131845d2_ex5-1.htm EX-5.1 19695
4 EXHIBIT 23.1 tm2131845d2_ex23-1.htm EX-23.1 2942
5 GRAPHIC lg_arbutusbiopharma-4c.jpg GRAPHIC 80220
6 GRAPHIC tm2131845d2_ex5-1img001.jpg GRAPHIC 3889
7 GRAPHIC tm2131845d2_ex5-1img002.jpg GRAPHIC 8880
  Complete submission text file 0001104659-21-134486.txt   919369
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260782 | Film No.: 211381032
SIC: 2834 Pharmaceutical Preparations